Business Standard

Dr Reddy's Q3 net profit up 45% at Rs 485 crore on lower tax outgo

It may be recalled that the company's net profit had declined 29 per cent in the year ago period

Dr Reddy's
Premium

BS Reporter Hyderabad
Drug major Dr Reddy's Laboratories Limited has reported a 45 per cent jump in net profit at Rs 485.2 crore for the quarter ended December, 2018 due to lower base and lower tax outgo as compared to Rs 334.4 crore in the corresponding quarter previous year.

It may be recalled that the company's net profit had declined 29 per cent in the year ago period.

Despite 8 per cent revenue decline in the US, which is its largest market, Dr Reddy's has managed to increase the overall revenues by 1 percent at Rs 3,850 crore for the third quarter helped by a

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in